AbbVie Inc. (ABBV) has a consensus analyst rating of Buy, based on 40 analysts covering the stock. Of those, 27 recommend buying, 12 recommend holding, and 1 recommend selling.
The analyst consensus price target for ABBV is $256.15, representing a +21.8% upside from the current price of $210.32. Price targets range from a low of $223.00 to a high of $299.00.
